Skip to content

Transcutaneous acupoint electrical stimulation technique for pain relief after dental implant surgery

Transcutaneous acupoint electrical stimulation technique for pain relief after dental implant surgery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096007
Enrollment
Unknown
Registered
2025-01-16
Start date
2025-04-28
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dentition defect

Interventions

TEAS group:Treatment with Transcutaneous Electrical Acupoint Stimulation (TEAS)
sham-TEAS group:Treatment with sham Transcutaneous Electrical Acupoint Stimulation

Sponsors

Stomatological Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Patients aged between 18 and 40, who are capable of understanding and signing the informed consent, have no local inflammation, and require single-tooth implantation without the need for bone grafting, with a preference for female patients who are more sensitive to pain and have anxiety or fear regarding oral implant surgery or pain.

Exclusion criteria

Exclusion criteria: 1.Patients with missing key medical record information; 2.Chronic pain; 3.Pregnant or lactating, menstrual period; 4.Long-term use of medications such as hypnotics and antiepileptic drugs; 5.With electronic devices such as pacemakers or other medical electronic devices implanted in the body; 6.Sleep disorders; 7.Severe periodontitis;

Design outcomes

Primary

MeasureTime frame
VAS pain score;

Secondary

MeasureTime frame
sleep diary;Pain relief needs;wound healing index;

Countries

China

Contacts

Public ContactYuzhou Li

Stomatological Hospital of Chongqing Medical University

807284343@qq.com+86 23 88602305

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026